Market Cap | 1.03B | P/E | - | EPS this Y | 73.70% | Ern Qtrly Grth | -94.00% |
Income | -83.7M | Forward P/E | 14.31 | EPS next Y | 20.00% | 50D Avg Chg | -9.00% |
Sales | 366.23M | PEG | - | EPS past 5Y | - | 200D Avg Chg | -27.00% |
Dividend | N/A | Price/Book | 6.95 | EPS next 5Y | - | 52W High Chg | -52.00% |
Recommedations | 3.10 | Quick Ratio | 5.31 | Shares Outstanding | 124.02M | 52W Low Chg | 6.00% |
Insider Own | 8.67% | ROA | -10.15% | Shares Float | 80.55M | Beta | 0.96 |
Inst Own | 92.86% | ROE | -72.46% | Shares Shorted/Prior | 9.27M/8.44M | Price | 7.73 |
Gross Margin | 33.43% | Profit Margin | -22.85% | Avg. Volume | 1,642,793 | Target Price | 3.08 |
Oper. Margin | -24.41% | Earnings Date | Nov 11 | Volume | 1,980,855 | Change | -2.28% |
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California.
Canaccord Genuity | Hold | Aug 12, 24 |
Piper Sandler | Underweight | Aug 9, 24 |
Stifel | Hold | Jul 26, 24 |
Piper Sandler | Underweight | Jul 11, 24 |
DA Davidson | Buy | May 13, 24 |
TD Cowen | Hold | May 13, 24 |
Piper Sandler | Underweight | May 10, 24 |
DA Davidson | Buy | Mar 15, 24 |
Canaccord Genuity | Hold | Mar 14, 24 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Miller Brian Christopher | Director Director | Aug 17 | Buy | 5.81 | 60,000 | 348,600 | 91,450 | 08/21/23 |
Schillinger Doug K. | Director Director | Aug 16 | Buy | 6.1072 | 33,000 | 201,538 | 64,450 | 08/17/23 |
SAUNDERS BRENT L | - - | Aug 16 | Buy | 6.1026 | 59,380 | 362,372 | 5,827,453 | 08/17/23 |